By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Array BioPharma, Inc. 

3200 Walnut Street

Boulder  Colorado  80301  U.S.A.
Phone: 303-381-6600 Fax: 303-381-6697


SEARCH JOBS



Segment
Drug Discovery





Company News
Array BioPharma (ARRY) Withdraws Skin Cancer NDA for Binimetinib 3/20/2017 6:52:53 AM
Array BioPharma (ARRY) Has a Potential Blockbuster Melanoma Drug On Its Hands 2/10/2017 7:40:35 AM
Array BioPharma (ARRY) Reports Financial Results For The Second Quarter Of Fiscal 2017 2/9/2017 10:20:49 AM
Array BioPharma (ARRY) To Report Financial Results For The Second Quarter Of Fiscal 2017 On February 9, 2017 2/3/2017 11:42:53 AM
Pierre Fabre And Array BioPharma (ARRY) Release: COLUMBUS Phase 3 Study Results In BRAF-Mutant Melanoma Presented At Society For Melanoma Research Annual Congress 11/9/2016 10:27:43 AM
Array BioPharma (ARRY) Reports Financial Results For The First Quarter Of Fiscal 2017 11/1/2016 9:53:56 AM
Array BioPharma (ARRY) To Report Financial Results For The First Quarter Of Fiscal 2017 On November 1, 2016 10/25/2016 10:12:52 AM
Array BioPharma (ARRY) Announces Closing Of Public Offering And Full Exercise Of Option To Purchase Additional Shares 10/3/2016 9:48:56 AM
Array BioPharma (ARRY) Announces Proposed Public Offering Of Common Stock 9/28/2016 6:51:29 AM
Array BioPharma (ARRY) Rockets as Melanoma Drug Meets Endpoint in Phase III Study 9/26/2016 7:06:31 AM
12345678910...
//-->